Morgens Waterfall Vintiadis & Co’s Celgene Corp CELG Stock Holding History

Morgens Waterfall Vintiadis & Co’s Portfolio CELG Stock Details CELG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-19,000	Closed	-$1.98M	–	75
2017 Q4	$1.98M	Buy	19,000 +5,000	+36%	+$564K	1.56%	25
2017 Q3	$2.04M	Hold	14,000	–	–	1.71%	25
2017 Q2	$1.82M	Sell	14,000 -6,400	-31%	-$784K	1.77%	27
2017 Q1	$2.54M	Sell	20,400 -20,500	-50%	-$2.45M	2.24%	21
2016 Q4	$4.73M	Buy	40,900 +10,900	+36%	+$1.21M	4.53%	2
2016 Q3	$3.14M	Sell	30,000 -26,000	-46%	-$2.81M	2.74%	14
2016 Q2	$5.52M	Buy	56,000 +30,000	+115%	+$3.1M	5.11%	6
2016 Q1	$2.6M	Hold	26,000	–	–	1.8%	18
2015 Q4	$3.11M	Buy	+26,000	New	+$3.01M	1.3%	18
2015 Q3	–	Sell	-35,000	Closed	-$4.05M	–	56
2015 Q2	$4.05M	Hold	35,000	–	–	2.55%	13
2015 Q1	$4.04M	Hold	35,000	–	–	2.59%	15
2014 Q4	$3.92M	Buy	+35,000	New	+$3.69M	2.19%	20
2013 Q4	–	Sell	-50,000	Closed	-$3.85M	–	58
2013 Q3	$3.85M	Hold	50,000	–	–	2.83%	13
2013 Q2	$2.92M	Buy	+50,000	New	+$3.01M	2.23%	16

Other funds holding CELG

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Edgewood Management Greenwich, Connecticut $15.5B AUM 9.67% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Morgens Waterfall Vintiadis & Co's CELG Position: Q1 2018 in Review

Morgens Waterfall Vintiadis & Co sold out of Celgene Corp (CELG) in Q1 2018, closing a stake of 19,000 shares — an estimated $1.98M sold.

Morgens Waterfall Vintiadis & Co first reported a position in CELG in Q2 2013 and held it in 14 quarters. The position peaked at $5.52M in Q2 2016. 1,397 funds tracked by Wall St. Rank hold CELG as of Q1 2018.

Morgens Waterfall Vintiadis & Co reported no remaining Celgene Corp position as of Q1 2018 after selling out during the quarter.
Morgens Waterfall Vintiadis & Co sold 19,000 Celgene Corp shares in Q1 2018, an estimated $1.98M.
Morgens Waterfall Vintiadis & Co first reported a position in Celgene Corp in Q2 2013 and held it in 14 quarters.
Morgens Waterfall Vintiadis & Co's Celgene Corp position peaked at $5.52M in Q2 2016.
1,397 funds tracked by Wall St. Rank held Celgene Corp as of Q1 2018.

Based on Morgens Waterfall Vintiadis & Co's 13F filing for Q1 2018, filed 15 May 2018.